Circulating miRNAs spectra in plasma of multiple myeloma patients compared with healthy individuals
收藏官方服务：
资源简介：
Circulating miRNAs spectra in plasma of multiple myeloma patients compared with healthy individuals
应用场景：
创建时间：
2014-01-16
相关数据集
Transcriptome analysis of CHEK1 overexpression (AC or HC) VS control (A or H) and CHEK1 knockdown (AK_D or HK_D) VS control (AK or HK) in Mutiple Myeloma.
Transcriptome sequencing was used to analyze changes in related signaling pathways and gene expression in Mutiple Myeloma cells when CHEK1 was overexptressed or knocked down. Examination of eight cel
NIAID Data Ecosystem30
Table 3_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
BackgroundNeurobrucellosis (NB) is a rare complication of brucellosis that presentis with a variety of clinical symptoms, complicating its diagnosis. This study aimed to analyze the microRNA (miRNA) p
NIAID Data Ecosystem00
Bone Marrow Stromal Cell Induced Chromatin Remodeling and Associated Transcriptional Changes in Multiple Myeloma [RNA-Seq]
Differential gene expression analysis of three multiple myeloma cell lines without stromal co-culture (control) with stromal co-culture (condition) after 72 hours of exposure. Overall design: Differen
NIAID Data Ecosystem00
Table2_A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma.docx
BackgroundAccurate differentiation between lung adenocarcinoma (AC) and lung squamous cell carcinoma (SCC) is crucial owing to their distinct therapeutic approaches. MicroRNAs (miRNAs) exhibit variabl
NIAID Data Ecosystem00
qPCR panels for plasma microRNAs of responders versus non responders metastatic castration resistant prostate cancer patients to abiraterone acetate. qPCR panels for plasma microRNAs of responders versus non responders metastatic castration resistant prostate cancer patients to abiraterone acetate
Abiraterone acetate (AA) serves as a medication for managing persistent testosterone production in patients with metastatic castration-resistant prostate cancer (mCRPC). However, its efficacy varies a
NIAID Data Ecosystem00
